This inventor holds 3 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 2004-2009.
Company Filing History:
Years Active: 2004-2009
Title: Innovations by Peter Maeding in Radiopharmaceuticals
Introduction
Peter Maeding is an accomplished inventor based in Dresden, Germany. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative devices and processes that enhance the diagnosis and treatment of various medical conditions.
Latest Patents
One of Maeding's latest patents is a device and process for nucleophilic fluorination. This invention relates to a device and a process for nucleophilic fluorination of a substance, particularly for the synthesis of an F-labeled substance for examination using a positron emission tomograph. The device includes an anion exchange device for extracting [F]fluoride ions through adsorption from a target fluid. Additionally, it features a measurement device with a measurement chamber for assessing the initial radioactivity of the [F]fluoride ions, with the anion exchange device arranged at least partially within the measurement chamber.
Another notable patent by Maeding is directed towards the use of radiopharmaceuticals for diagnosing Alzheimer's disease. This invention focuses on radiopharmaceuticals that can pass through the blood-brain barrier and bind to the CCR1 receptor present in the brain tissue of patients suffering from Alzheimer's disease. These innovations have the potential to significantly improve diagnostic capabilities in the medical field.
Career Highlights
Peter Maeding is currently associated with Schering Aktiengesellschaft, a company known for its advancements in pharmaceuticals and healthcare. His work at Schering has allowed him to contribute to groundbreaking research and development in the field of radiopharmaceuticals.
Collaborations
Throughout his career, Maeding has collaborated with notable colleagues, including Christoph-Stephan Hilger and Bernd Johannsen. These collaborations have fostered a productive environment for innovation and have led to the successful development of his patented technologies.
Conclusion
Peter Maeding's contributions to the field of radiopharmaceuticals exemplify the impact of innovative thinking in medicine. His patents not only advance diagnostic techniques but also pave the way for future research in the treatment of complex diseases.